We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CNA:NYSECNA Financial Corporation Analysis

Data as of 2026-03-15 - not real-time

$46.59

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

CNA Financial trades at a trailing P/E of 9.9, well below the industry average of 16.3, and offers a dividend yield of 4.1% with a payout ratio under 40%, indicating attractive income potential. The stock sits just above its technical support at $46.21 and below the 20‑day SMA of $48.20, reflecting a bullish long‑term trend despite a recent bearish MACD crossover and a RSI of 39 that hints at slight oversold conditions. Q4 earnings missed consensus estimates, yet the board raised the dividend, signaling confidence in cash flow, while analysts have a underperform rating and a target price of $43, suggesting near‑term downside pressure. The company’s balance sheet shows modest leverage (debt‑to‑equity ~27%) and strong free cash flow, supporting the sustainability of the dividend. Volatility over the past 30 days is elevated at roughly 26% but beta remains low at 0.43, indicating limited market‑wide risk. Overall, CNA appears undervalued from a fundamentals standpoint, but short‑term technical weakness and earnings disappointment temper immediate optimism.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Q4 earnings miss and bearish MACD signal
  • Proximity to technical support level
  • Analyst underperform rating with lower target price

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Significant valuation discount to peers
  • Strong dividend yield and sustainable payout
  • Low beta offsetting moderate volatility

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Fundamentally cheap (low P/E, low P/B) relative to industry
  • Robust cash generation supporting dividend continuity
  • Potential upside if market re‑prices the DCF fair value gap

Key Metrics & Analysis

Financial Health

Revenue Growth3.80%
Profit Margin8.53%
P/E Ratio9.9
ROE11.55%
ROA1.61%
Debt/Equity27.44
P/B Ratio1.1
Op. Cash Flow$2.5B
Free Cash Flow$2.3B
Industry P/E16.4

Technical Analysis

TrendBullish
RSI39.3
Support$46.21
Resistance$50.12
MA 20$48.20
MA 50$47.74
MA 200$46.62
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair Value$136.67
Target Price$43.00
Upside/Downside-7.71%
GradeUndervalued
TypeValue
Dividend Yield4.12%

Risk Assessment

Beta0.43
Volatility25.84%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.